Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions

SIMPLE SUMMARY: Triple negative breast cancer, a subtype of breast cancer that does not respond to hormone therapy, is typically more aggressive and affects younger patients. Treatment has traditionally been limited to chemotherapy, with poor survival for patients with advanced disease. More recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Laura, Okines, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417818/
https://www.ncbi.nlm.nih.gov/pubmed/37568617
http://dx.doi.org/10.3390/cancers15153801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417818/
https://www.ncbi.nlm.nih.gov/pubmed/37568617
http://dx.doi.org/10.3390/cancers15153801

Ejemplares similares